Menu Search
Equities

Sernova Corp

PSH:BER

Sernova Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.1548
  • Today's Change-0.001 / -0.71%
  • Shares traded115.00
  • 1 Year change-67.47%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 10:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CADView more

In 2023, Sernova Corp increased its cash reserves by 130.98%, or 4.95m. Cash Flow from Investing totalled 34.78m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 30.34m for operations while cash generated from financing totalled 503.46k.
Cash flow per share-0.1267
Price/Cash flow per share--
Book value per share-0.0413
Tangible book value per share-0.0417
More ▼

Balance sheet in CADView more

Sernova Corp uses little or no debt in its capital structure.
Current ratio0.3192
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.